Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
Te puede gustar
Ganadores
Últimas noticias cripto
Jiangnan Technology se une a SynVista para lanzar la plataforma de minería ecológica de IA
El ETF Ethereum Spot de EE.UU. experimenta 5 días consecutivos de flujos de entrada netos que finalizan, con un flujo de salida neto de 79 millones de dólares ayer.
Sospechoso Ethena Labs retira otros 25 millones de ENA
Comerciante de ballenas de ayer que se cortocircuitó perfectamente antes de que la caída mayor se alargue en ETH con 2x de apalancamiento, manteniendo una posición por valor de 56 millones de dólares
Tom Lee: S&P 500 subirá a 7300, alza en liquidez de mercado podría ser explosiva
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y CM:[email protected]
Servicios VIP:[email protected]